Princess Mette-Marit of Norway undergoes successful lung transplant

Norwegian Crown Princess Mette-Marit has received a successful lung transplant to treat advanced pulmonary fibrosis. The operation, performed at Oslo University Hospital, was made possible through the Scandiatransplant network, with the donor organ coming from another Scandinavian country while the donor’s identity remains anonymous. Post‑surgery, she will require lifelong immunosuppressive medication and regular monitoring to prevent organ rejection and manage infection risks.

The transplant has drawn public attention to the Norwegian royal family, which is already facing several health‑related challenges. Royal officials announced the procedure promptly to maintain public confidence in the organ‑allocation system, emphasizing that assignments are based solely on medical criteria. The high‑profile case has spurred a rise in organ‑donation registrations across Norway, highlighting the broader societal impact of the princess’s recovery journey.